ArticleAesthetic plastic surgery2025
Versatility of Diagon\Gel 4Two Implants in Aesthetic and Reconstructive Breast Surgery.
Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBreast augmentation and breast reconstruction with implants are among the most performed surgery worldwide.
objectiveIn the search for an ideal implant in terms of safety, shape and consistency, the authors report their experience with a subtype of breast implant, the Diagon\Gel 4Two implants, in both cosmetic and reconstructive cases by analyzing their experience on 116 consecutive patients.
methodsOne hundred and sixteen consecutive patients undergoing both aesthetic and reconstructive breast surgery using Diagon\Gel 4Two Implants between January 2021 and December 2022 were retrospectively reviewed. The analysis was performed dividing the patients in aesthetic and reconstructive cohort. Early and late complications, cosmetic outcome analysis and patients' satisfaction were registered for both cohorts.
resultsOn a total of 116 patients, 99 were cosmetic patients and 17 reconstructive cases. The follow-up time was 18 to 24 months. No major early and late complications were experienced. The outcomes were graded as very good to excellent in over 80% for the cosmetic cohort and in 72% of the reconstructive cohort. Patients' satisfaction was high to very high.
conclusionDiagon\Gel Implants is a subtype of anatomical silicone-gel filled implant with peculiar dual gel construct, unique three-dimensional configuration and available with micropolyurethane shell. In our experience, this implant resulted safe, with very low complication rate and very versatile for both primary and secondary cosmetic and reconstructive breast surgery. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
39715866What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.